Biomerica Inc. (BMRA) Insider Trading

Cluster buy

5 insiders bought $158k of their own stock in 7 days.

Open-market purchases by executives and directors between Aug 20 and Aug 26. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$158k

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

5 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 26, 2026

Get an email when BMRA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 26	David Moatazedi Director	Bought	10,000	$1.60	$16k	33%	Form 4
Aug 26	Eric Chin Director	Bought	6,250	$1.60	$10k	19%	Form 4
Aug 26	Allen Barbieri Executive Vice Chairman	Bought	20,000	$1.60	$32k	37%	Form 4
Aug 26	Zackary S. Irani Chief Executive Officer	Bought	31,250	$1.60	$50k	15%	Form 4
Aug 20	M. Huff Gary Director	Bought	31,250	$1.60	$50k	156%	Form 4

Aug 26
David Moatazedi
Director · bought 10,000 at $1.60
$16k
33% of stake
Aug 26
Eric Chin
Director · bought 6,250 at $1.60
$10k
19% of stake
Aug 26
Allen Barbieri
Executive Vice Chairman · bought 20,000 at $1.60
$32k
37% of stake
Aug 26
Zackary S. Irani
Chief Executive Officer · bought 31,250 at $1.60
$50k
15% of stake
Aug 20
M. Huff Gary
Director · bought 31,250 at $1.60
$50k
156% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BMRA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: In Vitro & In Vivo Diagnostic Substances

VNRXVolitionRx Limited

IMDXInsight Molecular Diagnostics Inc.

QCLSQ/C Technologies, Inc.

ICCCImmuCell Corporation

CRISCuris Inc.

CAMPCamp4 Therapeutics Corp.

ENSCEnsysce Biosciences Inc.

OCGNOcugen Inc.

Spot a number that looks wrong? Check it in BMRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BMRA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.